Table 2 Site of primary cancer and incidence of venous thrombosis by primary cancer site
Site | N (%) | Cumulative number of CAT cases at 3 months | Cumulative numbers of CAT cases at 6 months (%)a) | Cumulative numbers of CAT cases at 12 months |
|---|---|---|---|---|
H&N cancersb) | 257 (2.2) | 3 | 4 (1.56%) | 5 |
Esophageal | 137 (1.2) | 3 | 5 (3.65%) | 5 |
Stomach | 946 (8.1) | 22 | 29 (3.10%) | 30 |
Breast | 3,352 (28.6) | 2 | 7 (0.21%) | 9 |
Lung | 2,166 (18.5) | 31 | 41 (1.89%) | 56 |
Liver | 167 (1.4) | 5 | 5 (2.99%) | 8 |
Biliary | 196 (1.7) | 7 | 11 (5.61%) | 13 |
Pancreas | 481 (4.1) | 15 | 20 (4.16%) | 28 |
Colorectal | 2,236 (19.1) | 23 | 32 (1.43%) | 39 |
Kidney | 90 (0.8) | 5 | 6 (6.67%) | 6 |
Bladder | 109 (0.9) | 1 | 4 (3.67%) | 4 |
Gynecologic | 963 (8.2) | 26 | 33 (3.43%) | 41 |
Prostate | 37 (3.2) | 1 | 1 (2.70%) | 3 |
Testis | 25 (0.2) | 0 | 0 (0%) | 0 |
Lymphoma | 552 (4.7) | 6 | 9 (1.63%) | 14 |
Total | 11,714 (100) | 150 | 207 (1.77%) | 261 |